Comparing two radiation doses for partial breast treatment
Part of Cancer, Skin clinical trials.
This trial compares two slightly different doses of radiation (26 Gy vs 30 Gy) given in five quick sessions to just the part of the breast where cancer was removed. It is for people 50 and older with small, early-stage, non-aggressive breast cancers that are hormone positive and HER2 negative.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years or older.
- Your breast cancer is either invasive ductal carcinoma (IDC) or ductal carcinoma in situ (DCIS) that is 2 cm or smaller.
- Your cancer is hormone receptor positive and HER2 negative.
- You have not had radiation to the same breast before, and you are not getting chemotherapy or certain other treatments now.
- Your cancer has not spread to lymph nodes, and your surgery had clear margins (all cancer removed).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a very short, high-dose radiation treatment given directly to the breast after lumpectomy. It aims to make radiation more convenient by finishing in just a few days instead of weeks, possibly with fewer side effects.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This trial tests whether a shorter, 3-day course of partial breast radiation after surgery works as well as standard radiation for women with early-stage breast cancer. It may help reduce time in treatment while aiming to keep cancer from coming back in the treated breast area.
This trial tests a shorter course of radiation to just part of the breast before surgery for women who have had breast cancer return in the same breast. It's for those who have already had radiation to that breast and have a specific type of cancer (ER+, HER2-).
This trial studies a radiation technique that treats only part of the breast using a faster schedule. It may help some people with early breast cancer after breast-conserving surgery by delivering effective treatment with less radiation to the rest of the breast.
This trial tests a short, more intense radiation schedule for women with certain breast cancer types or who are under 40. It aims to reduce treatment time while still targeting the whole breast and any high-risk areas.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.